LOGO
LOGO

Quick Facts

Main Street Capital Closes Public Offering Of 3.75 Mln Shares - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Main Street Capital Corp. (MAIN) announced the closing of its previously announced underwritten public offering of 3.75 million shares of common stock at a public offering price of $22.50 per share.

In addition, the underwriters fully exercised their option to purchase 562,500 additional shares of the company's common stock to cover over-allotments. Including the exercise of the over-allotment option, the total number of shares sold in the offering was 4.31 million, the company stated.

Main Street said that the net proceeds from the offering, including exercise of the over-allotment option but after deducting underwriting discounts and estimated offering expenses payable by the company, were approximately $93.0 million.

Main Street intends to use the net proceeds from this offering, including the net proceeds from the exercise of the underwriters' over-allotment option, to make portfolio investments in accordance with its investment objective and strategies, to make investments in marketable securities and idle funds investments, to repay outstanding debt borrowed under its credit facility, to pay operating expenses and other cash obligations, and for general corporate purposes.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19